Tag: Mineralys Therapeutics

[NASDAQ] Mineralys Therapeutics, Inc. (MLYS) +5.87% : Guggenheim Reaffirms “Buy” Rating for Mineralys Therapeutics (NASDAQ:MLYS) (2025-03-10)

USA STOCK

March 11, 2025

STOCKNEWS

Mineralys Therapeutics, Inc. (MLYS) MLYS Chart as of 2025-03-10 Stock Information CEO: – CFO: – Employees: 51 Address: 150 N. Radnor Chester Rd., Radnor, PA, United States Country: United States Website: https://mineralystx.com Listing Date: – Founded: – Founder: – Current Price: 14.960000038146973 USD Today Change: 5.87% Outstanding Shares: 49,835,600 Volume: 15,069,270 Avg Volume: 283,155 Expert… Read more